Literature DB >> 2160562

Ultrastructural localization of Charcot-Leyden crystal protein (lysophospholipase) and peroxidase in macrophages, eosinophils, and extracellular matrix of the skin in the hypereosinophilic syndrome.

A M Dvorak1, P F Weller, R A Monahan-Earley, L Letourneau, S J Ackerman.   

Abstract

Electron microscopy, ultrastructural cytochemistry, and postembedding immunogold ultrastructural immunocytochemistry were used to study a papular cutaneous lesion from a patient with the hypereosinophilic syndrome. Peroxidase activity was detected cytochemically in 40-microns sections of skin utilizing the substrate diaminobenzidine; Charcot-Leyden crystal (CLC) protein was detected immunocytochemically in skin utilizing a postembedding immunogold technique; and a combined method was used where postembedding immunogold staining of CLC protein was performed on sections previously prepared to detect peroxidase activity. We describe a unique, eosinophil-rich inflammatory process in involved skin which contained extraordinary numbers of morphologically activated macrophages. Electron microscopy demonstrated (a) widespread eosinophil necrosis, (b) interstitial CLC formation, (c) macrophage activation, endocytosis, and phagocytosis, and (d) CLC formation in phagosomes of activated macrophages. Peroxidase activity was present as follows: (a) in the matrix of eosinophil specific granules in eosinophil cytoplasm, in membrane-bound specific granules released into interstitial tissues from dying eosinophils, being phagocytized by activated macrophages, and within macrophage phagosomes; (b) as amorphous interstitial debris; (c) in cytoplasm and nuclei of damaged eosinophils in the dermal tissues as well as in macrophage phagosomes; and (d) in endocytotic vesicles and vacuoles of macrophages and in CLC-containing phagosomes of macrophages. CLC protein was localized by immunocytochemistry to (a) eosinophil primary granules, (b) cytoplasm and nuclei of damaged eosinophils located in the interstitial tissues or within macrophage phagosomes, (c) CLC located in interstitial tissues adjacent to necrotic eosinophils and in macrophage phagosomes, and (d) aggregates of amorphous protein bound to macrophage surfaces; endocytotic vesicles and vacuoles of macrophages; amorphous protein aggregates in macrophage lysosomes.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2160562

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  11 in total

1.  Eosinophil granulocytes account for indoleamine 2,3-dioxygenase-mediated immune escape in human non-small cell lung cancer.

Authors:  Simonetta Astigiano; Barbara Morandi; Roberta Costa; Luca Mastracci; Antonella D'Agostino; Giovanni Battista Ratto; Giovanni Melioli; Guido Frumento
Journal:  Neoplasia       Date:  2005-04       Impact factor: 5.715

Review 2.  Crystal-storing histiocytosis: report of a case, review of the literature (80 cases) and a proposed classification.

Authors:  Snjezana Dogan; Leon Barnes; Wilhelmina P Cruz-Vetrano
Journal:  Head Neck Pathol       Date:  2012-03-20

3.  Intracellular crystal formation as a mechanism of cytotoxicity in murine pulmonary Cryptococcus neoformans infection.

Authors:  M Feldmesser; Y Kress; A Casadevall
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

4.  Mature eosinophils stimulated to develop in human-cord blood mononuclear cell cultures supplemented with recombinant human interleukin-5. II. Vesicular transport of specific granule matrix peroxidase, a mechanism for effecting piecemeal degranulation.

Authors:  A M Dvorak; S J Ackerman; T Furitsu; P Estrella; L Letourneau; T Ishizaka
Journal:  Am J Pathol       Date:  1992-04       Impact factor: 4.307

Review 5.  Piecemeal degranulation in human eosinophils: a distinct secretion mechanism underlying inflammatory responses.

Authors:  Rossana C N Melo; Peter F Weller
Journal:  Histol Histopathol       Date:  2010-10       Impact factor: 2.303

6.  Eosinophil protein in airway macrophages: a novel biomarker of eosinophilic inflammation in patients with asthma.

Authors:  Neeta S Kulkarni; Fay Hollins; Christopher E Brightling; Amanda Sutcliffe; Ruth Saunders; Sachil Shah; Salman Siddiqui; Sumit Gupta; Pranab Haldar; Ruth Green; Ian Pavord; Andrew Wardlaw
Journal:  J Allergy Clin Immunol       Date:  2010-07       Impact factor: 10.793

7.  Presence in human eosinophils of a lysophospholipase similar to that found in the pancreas.

Authors:  F W Holtsberg; L E Ozgur; D E Garsetti; J Myers; R W Egan; M A Clark
Journal:  Biochem J       Date:  1995-07-01       Impact factor: 3.857

8.  Mature eosinophils stimulated to develop in human cord blood mononuclear cell cultures supplemented with recombinant human interleukin-5. Part I. Piecemeal degranulation of specific granules and distribution of Charcot-Leyden crystal protein.

Authors:  A M Dvorak; T Furitsu; L Letourneau; T Ishizaka; S J Ackerman
Journal:  Am J Pathol       Date:  1991-01       Impact factor: 4.307

9.  Vesicle-mediated secretion of human eosinophil granule-derived major basic protein.

Authors:  Rossana C N Melo; Lisa A Spencer; Sandra A C Perez; Josiane S Neves; Staci P Bafford; Ellen S Morgan; Ann M Dvorak; Peter F Weller
Journal:  Lab Invest       Date:  2009-04-27       Impact factor: 5.662

10.  Kinetic studies of galectin-10 release from eosinophils exposed to proliferating T cells.

Authors:  C Lingblom; K Andersson; C Wennerås
Journal:  Clin Exp Immunol       Date:  2020-11-17       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.